Among patients on PPI therapy, all hematologic indices decreased from baseline, including hemoglobin (-0.19 g/dL, P=0.03), hematocrit (-0.63%, P=0.02), and mean corpuscular volume (-0.49 fL, P=0.05)
Newer compounds, including agents like NLY01 and tirzepatide, are being developed to improve brain penetration and potentially enhance neurological effects, says Ali
DiFeliceantonio and her colleagues set out to test this hypothesis
For Alzheimers disease, researchers gave 204 participants with mild to moderate disease liraglutide (a GLP-1 that pre-dated Ozempic) and measured how much brain volume they lost
What are the signs you might need a B12 injection
Positive Patient Outcomes and Testimonials The success stories and positive testimonials from our patients highlight the transformative impact of our treatments